XTalks

OCTOBER 12, 2022

Features of blood perfusion in the brain detected by MRI now have clinical applications in central nervous system (CNS) cancers, neurodegenerative disease, cerebrovascular disease and demyelinating disease. It is also easy to apply for the kidneys because only the renal arteries feed the kidneys,” explained Ashton.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

XTalks

AUGUST 17, 2020

To learn more about innovations in the field, Xtalks spoke to Anish Suri, PhD, president and chief scientific officer of Cue Biopharma about the company’s initiatives in the development of immune-based biological compounds for the treatment of cancers and autoimmune diseases. cells, receptors) to treat disease. 101, 102, 103).

Protein 98

Protein Engineer Immune Response In-Vivo 98

XTalks

JANUARY 19, 2024

Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer.

DNA 66

DNA Radiology FDA Approval Development 66

The Pharma Data

MAY 4, 2021

Rare Disease. and developed Europe following the approvals in 2019 for combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma; as well as. The vaccine was 100% effective against severe disease as defined by the U.S. Internal Medicine.

Vaccination 40

Vaccination Vaccine Production Sales 40